Ketek is a brand name of telithromycin, approved by the FDA in the following formulation(s):
KETEK (telithromycin - tablet; oral)
Manufacturer: SANOFI AVENTIS US
Approval date: April 1, 2004
Strength(s): 400MG [RLD]
Manufacturer: SANOFI AVENTIS US
Approval date: February 9, 2005
Strength(s): 300MG
Has a generic version of Ketek been approved?
No. There is currently no therapeutically equivalent version of Ketek available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ketek. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Erythromycin compounds
Patent 5,635,485
Issued: June 3, 1997
Inventor(s): Agouridas; Constantin & Chantot; Jean-Francois & Denis; Alexis & D'Ambrieres; Solange G. & Martret; Odile L.
Assignee(s): Roussel Uclaf
An erythromycin compound of Formula I or its non-toxic acid addition salt having antibiotic activity.Patent expiration dates:
- April 1, 2018✓✓✓
- April 1, 2018
Pill tablet
Patent D459798
Issued: July 2, 2002
Inventor(s): Christian; Desesquelle & Philippe; Becourt
Assignee(s): Aventis Pharma S.A.Patent expiration dates:
- September 24, 2015✓
- September 24, 2015
See also...
- Ketek Consumer Information (Drugs.com)
- Ketek Consumer Information (Wolters Kluwer)
- Ketek Consumer Information (Cerner Multum)
- Ketek Advanced Consumer Information (Micromedex)
- Ketek AHFS DI Monographs (ASHP)
- Telithromycin Consumer Information (Wolters Kluwer)
- Telithromycin Consumer Information (Cerner Multum)
- Telithromycin Advanced Consumer Information (Micromedex)
- Telithromycin AHFS DI Monographs (ASHP)
No comments:
Post a Comment